On Demand
Duration: 30 minutes
Sign up to watch the webinar:
What you’ll learn:
Thousands of data issues plague the average clinical trial — and 75% of them slip through traditional reconciliation processes. The results: delayed decisions, compliance risk, compromised biomarker integrity, and operational strain across sites, labs, and submission teams.
Tune in to learn how QuartzBio’s Precision Medicine agentic framework, powered by proactive and prescriptive AI, is redefining operational intelligence across biospecimen and biomarker lifecycles. Our Sample Intelligence AI Agents monitor samples, detect emerging issues, automatically flag root causes, and deliver actionable, corrective guidance directly to teams through a secure, personalized Virtual Assistant—enabling faster intervention and fewer surprises.
Tobi Guennel, Ph.D., QuartzBio’s Chief Technology Officer, will demonstrate how our agentic framework:
- Enables real-time decision-making across trial workflows
- Reduces data issues and compliance risks by over 80% before they impact timelines
- Facilitates compliance with ICH E6(R3) and other regulations by automating data federation, ensuring data integrity, and managing governance
- Protects biomarker and biospecimen integrity, from chain of custody to downstream analytics
QuartzBio’s AI agents empower R&D teams to shift from manual oversight to strategic innovation—shortening trial timelines, improving regulatory adherence, and driving operational excellence across the R&D value chain.
Who should attend:
- Biomarker Operations and Biospecimen Operations Teams
- Clinical Operations Teams
- Regulatory Compliance and Quality Teams
- Translational Scientists
- R&D Information Technology (IT)
